Drug Pipeline

Angiotensin II Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
1
Recruiting
1
Phase 3
4
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT06746753
Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock		 date change Primary completion pushed: 2028-07 -> 2028-09-30
2026-06-05 NCT06746753
Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock		 date change Completion pushed: 2028-08 -> 2028-10-07
Active Studies by Phase
Phase 4
1
Phase 2/3
1
Phase 2
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06746753 Mechanistic Assessment of Norepinephrine Therapy vs. Angiotensin-II in Septic Shock Septic Shock Not Yet Recruiting
Phase 2/3
NCT04901169 Angiotensin II in Liver Transplantation Liver Transplant; Complications Active, Not Recruiting
Phase 2
NCT07312292 Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose… Liver Cancer (Locally Advanced or Metastatic) Recruiting
Early Phase 1
NCT07568275 Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance Septic Shock Active, Not Recruiting
Sponsors Running Angiotensin II Trials
University of California, San Francisco (1) Wake Forest University Health Sciences (1) Niek Wijnen (1) The Cleveland Clinic (1)
Disease Areas
Liver Cancer (1)
Get alerts when Angiotensin II trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free